
Julie Chang, MD, discusses the reasoning behind the development of a minimal residual disease-adapted study in patients with previously untreated mantle cell lymphoma.

Your AI-Trained Oncology Knowledge Connection!

Julie Chang, MD, is an associate professor of medicine at the University of Wisconsin School of Medicine and Public Health in Madison, WI.